New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive wasting away of the nerve cells in the brain and spinal column that control the muscles that allow movement. Over a period of months or years, ALS causes increasing muscle weakness, inability to control movement, and problems with speaking, swallowing, and breathing.
The cause of ALS is unknown, and there is no cure. Treatment focuses on helping you keep your strength and independence for as long as possible. Treatment includes medicines to slow the disease and help with symptoms, physical therapy, occupational therapy, speech therapy, and supportive devices to help with daily tasks.
Clinical Trials for Amyotrophic Lateral Sclerosis (ALS)
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Amyotrophic Lateral Sclerosis (ALS)
Lou Gehrig's disease, or amyotrophic lateral sclerosis (ALS), is a progressive neurodegenerative disease. The brain's loss in muscle control results in paralysis.
Amyotrophic Lateral Sclerosis
ALS
lou-gehrig's-disease
rarely charcot disease
ALS treatment